Evidence map›Paper›PMID 41809734›Full record

ArticleInternational journal of cardiology. Cardiovascular risk and prevention2026

Thrombaxane-B2 as a predictor marker of atrial fibrillation.

Luigi Petramala, Roberto Carnevale, Luca Marino, Luca D'Ambrosio, Simona Bartimoccia, Elisa Alessandra D'Amico, Vittorio Picchio, Angela Leonardo, Elisa Dietrich, Maurizio Forte and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of cardiology. Cardiovascular risk and prevention, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Luigi PetramalaDepartment of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Roberto CarnevaleDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Luca MarinoDepartment of Mechanical and Aerospace Engineering, "Sapienza" University of Rome, Rome, Italy.
Luca D'AmbrosioIRCCS Neuromed, Località Camerelle, 86077, Pozzilli, IS, Italy.
Simona BartimocciaDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Elisa Alessandra D'AmicoIRCCS Neuromed, Località Camerelle, 86077, Pozzilli, IS, Italy.
Vittorio PicchioDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Angela LeonardoDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Elisa DietrichDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Maurizio ForteIRCCS Neuromed, Località Camerelle, 86077, Pozzilli, IS, Italy.
Giacomo FratiDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Gioacchino GalardoDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Francesco CircostaDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
Sebastiano SciarrettaDepartment of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100, Latina, Italy.
Claudio LetiziaDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most frequent cardiac arrhythmia in clinical practice, and its global health burden is progressively rising due to the aging of the world population, progressively higher prevalence of obesity, and improved attention to its early detection; AF is linked to increased risk of several complications, as well as death, stroke and peripheral embolism. In recent years many efforts have been made to fully understand the pathophysiology of AF and its complications. Several epidemiological studies have been conducted to early identification of AF, in order to pay more attention to AF risk factors, including arterial hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea syndrome (OSAS), physical inactivity, and alcohol excess. While the traditional view attributes the primary cause of AF onset to myocardial remodelling (i.e. atrial dilatation, ventricular hypertrophy), cutting-edge research has increasingly highlighted a pivotal role for systemic and myocardial inflammation in the etiology of this arrhythmia. In this study we aimed to evaluate the clinical presentation and the inflammatory immunophenotype of individuals presenting with AF episode, evaluating several biomarkers, such as IFN-γ and thromboxane B2 (TXB

Indexed as

Atrial fibrillationBiomarkerInflammationThrombosis

Identifiers

PMID41809734
PMCPMC12969420

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.